Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
暂无分享，去创建一个
M. Sliwkowski | L. Amler | T. Januario | U. Matulonis | V. Paton | D. Dizon | K. Ng | F. Ueland | M. Gold | S. Makhija | S. Kelsey | Chine-Yu Lin | D. Glenn | A. Strauss